um Lancet study on cov shields now, which says that vaccine remained effective against the moderate to severe patients as well and covered 19 even during the search that was dominated by the highly transmissible delta variant of SARS Cove. To issue with us on that as well, we should take us in the details, please. So this is very important. Zonal because The Lancet study on COV Shield says that the vaccine remained effective against moderate to severe covet 19, even during a surge that was dominated by the highly transmissible Delta variant of CA Vin. Now, this test was actually done to evaluate rail world effectiveness off Coby Shield during the surge which we saw between April and May 2021 in our country. And as a result of this, what up the Lancet report now says is that vaccine effectiveness of Coby Shield in moderate to severe diseases 81% and there is a fairly staggering number. It's a It's a very good number which essentially shows that this vaccine protects people of in in in cases from hospitalisation. However, the overall vaccine effectiveness about 63% so 63% effectiveness against for people across all categories 81% in moderate to severe disease. So this again and indicators at this particular vaccine has worked well in India. The big question Is it going to work as effectively As far as Army crown is concerned, we should perhaps get a couple of answers to that later on today, or thanks for joining us with the very latest.
